Most Innovative Companies

Recursion Pharmaceuticals

Recursion Pharmaceuticals' mission is to make drug discovery and development faster and more effective using AI and experimental biology.

The company was founded in 2015, and since then it's introduced more than 50 drug programs. In July 2018, the FDA approved an investigational new drug application for REC-994 as a treatment for cerebral cavernous malformation, a genetic disease that affects approximately 1.5 million Americans. Enlarged, irregular blood vessels alter blood flow. Recursion identifies a drug candidate to ameliorate a disease like this using a machine learning platform to analyze billions of cellular images and map human cellular biology. 

headquarters: Salt Lake City, Utah
Recursion Pharmaceuticals On The Web